Author:
Schneeweiss Andreas,Goerner Ronald,Hensel Manfred,Lauschner Ilka,Sinn Peter,Kaul Sepp,Egerer Gerlinde,Beldermann Frank,Geberth Matthias,Solomayer Erich,Grischke Eva-Maria,Haas Reiner,Ho Anthony D.,Bastert Gunther
Subject
Transplantation,Hematology
Reference31 articles.
1. Malignant tumors of the breast;Harris,1997
2. Results of a randomized trial of adjuvant chemotherapy with FEC 50 vs FEC 100 in high risk node-positive breast cancer patients;Boneterre;Proc Am Soc Clin Oncol,1998
3. Randomized trial of intensive cyclophosphamide, epirubicin, and fluorouracil chemotherapy compared with cyclophosphamide, methotrexate, and fluorouracil in premenopausal women with node-positive breast cancer. National Cancer Institute of Canada Clinical Trials Group.
4. Better outcome of premenopausal nodepositive (N+) breast cancer patients (pts) treated with 6 cycles vs 3 cycles of adjuvant chemotherapy: eight year follow-up results of FASG 01;Fumolean;Proc Am Soc Clin Oncol,1999
5. High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer;Peters;J Clin Oncol.,1993
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献